A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...

PALM SPRINGS, Calif. (KESQ) -The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate cancer cases on the rise across the nation ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast cancer.